Evidence map›Paper›PMID 33883900›Full record

ArticleJournal of multidisciplinary healthcare2021

Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study.

Hassan Alwafi, Abdallah Y Naser, Sultan Qanash, Ahmad S Brinji, Maher A Ghazawi, Basil Alotaibi, Ahmad Alghamdi, Aisha Alrhmani, Reham Fatehaldin, Ali Alelyani and 5 more

Abstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hassan AlwafiFaculty of Medicine, Umm Al Qura University, Mecca, Saudi Arabia.
Abdallah Y NaserDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan.
Sultan QanashKing Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah, Saudi Arabia.ORCID 0000-0002-7346-8291
Ahmad S BrinjiDepartment of Radiology, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Maher A GhazawiDepartment of Radiology, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Basil AlotaibiCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-3730-0854
Ahmad AlghamdiDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Aisha AlrhmaniDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Reham FatehaldinDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Ali AlelyaniDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Abdulrhman BasfarDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Abdulaziz AlBarakatiDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Ghaidaa F AlsharifDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Elaf F ObaidDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.
Mohammed ShabrawishiDepartment of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 pandemic is a major strain on health and economic systems, with rapidly increasing demand for in patients' facilities. Disease diagnosis and estimating patients at higher risk is important for the optimal management during the pandemic. This study aimed to identify the predictors of mortality and length of hospital stay in COVID-19 patients.

methodsA retrospective cross-sectional study was conducted between March 2020 and August 2020 at Al-Noor Specialist Hospital in Mecca, Saudi Arabia. All patients who were admitted and had a confirmed COVID-19 diagnosis by a real-time polymerase chain reaction (PCR) were included in the study. Descriptive statistics were used to describe patients' demographic characteristics, laboratory findings, and clinical outcomes. Multiple logistic/linear regression analysis was used to identify predictors of death and length of stay at the hospital.

resultsA total of 706 patients were hospitalised for COVID-19. The mean age was 48.0 years (SD: 15.6 years). More than half of the patients (68.5%; n= 292) were males. The median duration of stay at the hospital was 6.0 days (IQR: 300-10:00). The prevalence rate of venous thromboembolism (VTE) among the patients was 3.0% (n= 21). In the multivariate logistic regression analysis, age (AOR: 1.05; 1.02-1.09), patients with end-stage renal disease (AOR: 6.44; 2.20-18.87), low Oxygen saturation SPO2 (AOR: 9.92; 4.19-23.50), D.dimer >0.5 (AOR: 13.31; 5.45-32.49), ESR>10 mm/h (AOR: 4.08; 1.72-9.68), Ferritin>400mcg/L (AOR: 18.55; 6.89-49.96), and Procalcitonin>0.5ug/L (AOR: 8.23; 1.81- 37.40) were associated with a higher risk of death among patients with COVID-19. Patients with VTE (AOR: 12.86; 3.07- 53.92) were at higher risk of death due to COVID-19.

conclusionHospitalised COVID-19 patients have multiple negative consequences in terms of their laboratory findings, signs and symptoms. Age and end-stage renal diseases have a significant impact on the mortality rate and the length of hospital stay among COVID-19 patients.

Indexed as

COVID-19hospitalisationICUlength of staySaudi Arabiasurvival

Identifiers

PMID33883900
PMCPMC8055273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.